{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T20:09:28Z","timestamp":1778357368764,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["UG1 HL174426"],"award-info":[{"award-number":["UG1 HL174426"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["U01 AI184132"],"award-info":[{"award-number":["U01 AI184132"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["N00014-25-1-2146"],"award-info":[{"award-number":["N00014-25-1-2146"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["N00014-24-1-2057"],"award-info":[{"award-number":["N00014-24-1-2057"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75R60222C00011"],"award-info":[{"award-number":["75R60222C00011"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jtct.2025.12.949","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T16:22:41Z","timestamp":1765642961000},"page":"434.e1-434.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0024-9466","authenticated-orcid":false,"given":"Jennifer N.","family":"Saultz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Tsi","family":"Bolon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-6843","authenticated-orcid":false,"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7271-8252","authenticated-orcid":false,"given":"Stephen R.","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2600-6390","authenticated-orcid":false,"given":"Stephanie J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meilun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3461-8775","authenticated-orcid":false,"given":"Christine","family":"Camacho-Bydume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Chowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Paczesny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3255-8143","authenticated-orcid":false,"given":"Shahinaz M.","family":"Gadalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2855-4120","authenticated-orcid":false,"given":"Steven G.E.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3696-5803","authenticated-orcid":false,"given":"Esteban","family":"Arrieta-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jtct.2025.12.949_bib0001","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jtct.2025.12.949_bib0002","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GvHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.949_bib0003","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41409-025-02553-x","article-title":"Regulatory T cell therapy for graft-versus-host disease","volume":"60","author":"Lysandrou","year":"2025","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.949_bib0004","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jtct.2025.05.014","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy - a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.949_bib0005","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2025.12.949_bib0006","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood.2025028617","article-title":"Challenges in GvHD and GVL after hematopoietic stem cell transplantation for myeloid malignancies","volume":"146","author":"Socie","year":"2025","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.949_bib0007","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/s41467-023-38113-4","article-title":"Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantation","volume":"14","author":"Pagliuca","year":"2023","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.jtct.2025.12.949_bib0008","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood.2021013443","article-title":"HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide","volume":"139","author":"Fuchs","year":"2022","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.949_bib0009","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood-2017-07-798751","article-title":"Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion","volume":"131","author":"Oran","year":"2018","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.949_bib0010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.2020008464","article-title":"Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM","volume":"137","author":"Meurer","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.949_bib0011","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","article-title":"Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study","volume":"13","author":"Fleischhauer","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.949_bib0012","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","article-title":"Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction","volume":"46","author":"Abelin","year":"2017","journal-title":"Immunity"},{"issue":"16","key":"10.1016\/j.jtct.2025.12.949_bib0013","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1182\/blood.2024024351","article-title":"Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS","volume":"144","author":"Arrieta-Bola\u00f1os","year":"2024","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.949_bib0014","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/hematology.2022000326","article-title":"Hematology 2022-what is complete HLA match in 2022?","volume":"2022","author":"Spellman","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.949_bib0015","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtct.2025.07.004","article-title":"Allogeneic hematopoietic cell donor selection: contemporary guidelines from the NMDP\/CIBMTR","volume":"31","author":"Jimenez","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.949_bib0016","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.4049\/jimmunol.2000192","article-title":"Immunopeptidome analysis of HLA-DPB1 allelic variants reveals new functional hierarchies","volume":"204","author":"van Balen","year":"2020","journal-title":"J Immunol"},{"issue":"9","key":"10.1016\/j.jtct.2025.12.949_bib0017","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/molbev\/msy116","article-title":"Divergent allele advantage at human MHC genes: signatures of past and ongoing selection","volume":"35","author":"Pierini","year":"2018","journal-title":"Mol Biol Evol"},{"issue":"4154","key":"10.1016\/j.jtct.2025.12.949_bib0018","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.185.4154.862","article-title":"Amino acid difference formula to help explain protein evolution","volume":"185","author":"Grantham","year":"1974","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.jtct.2025.12.949_bib0019","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41591-019-0639-4","article-title":"Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy","volume":"25","author":"Chowell","year":"2019","journal-title":"Nat Med"},{"issue":"6375","key":"10.1016\/j.jtct.2025.12.949_bib0020","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy","volume":"359","author":"Chowell","year":"2018","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.949_bib0021","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/bjh.18561","article-title":"Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors","volume":"200","author":"Merli","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2025.12.949_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841470","article-title":"Class I\/class II HLA evolutionary divergence ratio is an independent marker associated with disease-free and overall survival after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia","volume":"13","author":"Daull","year":"2022","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.jtct.2025.12.949_bib0023","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/cancers12071835","article-title":"HLA evolutionary divergence as a prognostic marker for AML patients undergoing allogeneic stem cell transplantation","volume":"12","author":"Roerden","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jtct.2025.12.949_bib0024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-065X.1995.tb00674.x","article-title":"The origins of HLA-A,B,C polymorphism","volume":"143","author":"Parham","year":"1995","journal-title":"Immunol Rev"},{"issue":"23","key":"10.1016\/j.jtct.2025.12.949_bib0025","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.12.949_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1440911","article-title":"Human leukocyte antigen evolutionary divergence as a novel risk factor for donor selection in acute lymphoblastic leukemia patients undergoing haploidentical hematopoietic stem cell transplantation","volume":"15","author":"Cao","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2025.12.949_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.70088","article-title":"HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation","volume":"9","author":"Le Grand","year":"2025","journal-title":"Hemasphere"},{"issue":"2 suppl","key":"10.1016\/j.jtct.2025.12.949_bib0028","doi-asserted-by":"crossref","first-page":"S295","DOI":"10.1016\/j.jtct.2025.01.449","article-title":"New polymorphic antigen binding domain-based HLA evolutionary divergence score independently predicts AML relapse after haploidentical stem cell transplantation","volume":"31","author":"Katikaneni","year":"2025","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2025.12.949_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101766","article-title":"The biogenesis of the immunopeptidome","volume":"67","author":"Admon","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jtct.2025.12.949_bib0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.imlet.2022.05.001","article-title":"CD4+ cytotoxic T cells - phenotype, function and transcriptional networks controlling their differentiation pathways","volume":"247","author":"Preglej","year":"2022","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jtct.2025.12.949_bib0031","article-title":"The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"issue":"7780","key":"10.1016\/j.jtct.2025.12.949_bib0032","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"issue":"6685","key":"10.1016\/j.jtct.2025.12.949_bib0033","doi-asserted-by":"crossref","first-page":"eadi3808","DOI":"10.1126\/science.adi3808","article-title":"An immunogenetic basis for lung cancer risk","volume":"383","author":"Krishna","year":"2024","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.jtct.2025.12.949_bib0034","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa1808777","article-title":"Immune escape of relapsed AML cells after allogeneic transplantation","volume":"379","author":"Christopher","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jtct.2025.12.949_bib0035","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41591-019-0400-z","article-title":"Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation","volume":"25","author":"Toffalori","year":"2019","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.949_bib0036","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jtct.2025.12.949_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2024.101575","article-title":"From clones to immunopeptidomes: new developments in the characterization of permissive HLA-DP mismatches in hematopoietic cell transplantation","volume":"37","author":"Arrieta-Bola\u00f1os","year":"2024","journal-title":"Best Pract Res Clin Haematol"},{"issue":"12","key":"10.1016\/j.jtct.2025.12.949_bib0038","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.humimm.2022.09.004","article-title":"HLA-B evolutionary divergence is associated with outcomes after SARS-CoV-2 infection","volume":"83","author":"Hernandez","year":"2022","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.jtct.2025.12.949_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106763","article-title":"HLA-DP diversity is associated with improved response to SARS-Cov-2 vaccine in hematopoietic stem cell transplant recipients","volume":"26","author":"Villemonteix","year":"2023","journal-title":"iScience"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725026119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725026119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T19:33:11Z","timestamp":1778355191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725026119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2666636725026119"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.949","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher HLA-DRB1 Evolutionary Divergence Is Associated with Reduced Relapse and Improved Survival after Matched Unrelated Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.12.949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}